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Background
For several years now, Plasmodium falciparum is develop-
ing resistance to drugs in use. There is hence an urgent
need for new treatments as well as new targets. By identi-
fying the targets of novel or known active molecules with
unknown mechanisms of action, it is possible to guide the
development of new chemical entities towards their clini-
cal application. This project aims at finding the putative
target(s) of CP1, a new molecule in the development
phase, and of triclosan, a well-known antibacterial and
fungicide, by means of chemical proteomics and ligand
based inverse virtual screening.
Materials and methods
The parasite lysate was incubated with the affinity matrix
and retained proteins were analyzed by LC-MS/MS.
Yeasts complemented with plasmodial Hsp90 were
grown in minimal media. Viability was calculated by
comparison with untreated strains. Binding of CP1 deri-
vatives to purified N-terminal PfHsp90 was evaluated
with Differential Scanning Fluorimetry. For the identifi-
cation of potential triclosan binders, molecules were eval-
uated in silico using molecular docking program GOLD.
Inhibition of PfCDPK2 and mechanism of action of tri-
closan were evaluated with a radiometric assay using
myelin basic protein (MBP) as substrate.
Results
For CP1, chemical proteomics identified heat shock pro-
tein 90 (Hsp90) as a putative binder. Subsequent assays
confirmed that the viability of yeast cells where the wild-
type Hsp90 has been substituted with the plasmodial one
was strongly reduced in presence of CP1. Moreover, CP2
was proven to bind the N-terminal domain of PfHsp90.
R triclosan, the in silico inverse screening proposed the
calcium-dependent protein kinase 2 (PfCDPK2) as its
potential binding partner. Enzymatic assays confirmed
inhibition of PfCDPK2 with an IC50 of 48 µM. Further-
more, the mechanism of action was determined to be
non-competitive towards ATP.
Conclusion
This study shows that both chemical proteomics and in
silico approaches are valuable tools for the identification of
potential targets or binders of active molecules. The
results obtained so far for PfHsp90 point definitely
towards an interaction with the protein, although a direct
proof of inhibition is still needed. On the other side, the
confirmation of the inhibition of PfCDPK2 by triclosan
opens new perspectives in the use of this molecule and
derivatives thereof against Plasmodium falciparum. In
both cases, such results represent a starting point towards
the optimization of the molecules and the development of
new therapeutics against malaria.
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